MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-08-0011241
Alleviare Life Sciences Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹6.49 Cr
▲ 2% YoY
Net profit · FY 2025
₹37.54 Lakh
Net margin 5.8%
EBITDA · FY 2025
₹54.24 Lakh
EBITDA margin 8.4%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹4.28 Lakh
Issued & subscribed
Company age
13 yrs
Est. 2013
Directors on board
2
As per MCA filings
Active GSTINs
1
of 2 registered
About Alleviare Life Sciences Private Limited
Data last updated:
Alleviare Life Sciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 December 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2013PTC261897. Its GSTIN is 07AAMCA2111M1ZR (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4.28 Lakh. It is led by directors Vaibhav Bansal and Puneet Poddar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S – 9 Mezzanine Floor Uphaar Cinema Complex Green Park Extension, New Delhi, Delhi, India – 110016.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.49 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹37.54 Lakh (net margin 5.8%) and EBITDA of ₹54.24 Lakh (EBITDA margin 8.4%). Revenue has grown at a compounded annual rate (CAGR) of 43% over three years and 26% over five years.
The company is associated with 1 brand: Alleviare Life Sciences.
Alleviare Life Sciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0011241). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website alleviareindia.com.
Company details
CIN U74999DL2013PTC261897
Registration Number 261897
Incorporation Date 10 December 2013
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-08-0011241
Key People
Vaibhav Bansal Director Puneet Poddar Director Recognitions & Rankings of Alleviare Life Sciences
Contact details
Alleviare Life Sciences Private Limited's registered office is in New Delhi, Delhi. Its website is alleviareindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressS – 9 Mezzanine Floor Uphaar Cinema Complex Green Park Extension, New Delhi, Delhi, India – 110016
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Alleviare Life Sciences Private Limited, buy the company report.
Comprehensive company report
Alleviare Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Alleviare Life Sciences operates one associated brand: Alleviare Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical import and export services for personal use and international distribution. | alleviareindia.com |
Business activity
The main business activity of Alleviare Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Alleviare Life Sciences Private Limited, buy the company report.
Financials of Alleviare Life Sciences Private Limited
FY 2025 filings availableAlleviare Life Sciences Private Limited reported revenue of ₹6.49 Cr (up 2% YoY) for FY 2025.
Revenue · FY 2025
₹6.49 Cr ▲ 2%
Net profit · FY 2025
₹37.54 Lakh margin 5.8%
EBITDA · FY 2025
₹54.24 Lakh margin 8.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 2%
3 years · compounded
▲ 43%
5 years · compounded
▲ 26%
EBITDA CAGR growth
1 year
▲ 87%
3 years · compounded
▲ 108%
5 years · compounded
▲ 64%
Revenue has grown at a compounded annual rate (CAGR) of 26% over five years, including 2% growth in the latest year. EBITDA rose 87% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹54.24 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹37.54 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.4% | ||||
| Net Profit Margin | 5.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Alleviare Life Sciences Private Limited, buy the company report.
Board of directors of Alleviare Life Sciences Private Limited
Alleviare Life Sciences has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vaibhav Bansal | Director | 15 Nov 2023 | 2 Years 11 Months | Current |
| Puneet Poddar | Director | 15 Nov 2023 | 2 Years 11 Months | Current |
Peer comparison
Alleviare Life Sciences Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alwin Willcure Pharmaceuticals Private Limited | ₹6.52 Cr (FY 2025) | 15.0% | New Delhi, Delhi, India | |||
| Genesia Pharmaceuticals (India) Private Limited | ₹6.51 Cr (FY 2024) | 23.0% | Jaipur, Rajasthan, India | |||
| Alleviare Life Sciences Private Limitedthis company | ₹6.49 Cr (FY 2025) | ₹37.54 Lakh | 5.8% | 2.0% | New Delhi, Delhi, India | |
| Rawia International Healthcare Private Limited | ₹6.49 Cr (FY 2025) | -24.0% | Mumbai, Maharashtra, India | |||
| Daikon Pharmaceuticals Private Limited | ₹6.49 Cr (FY 2025) | 7.0% | Delhi, India | |||
| Bravo Pharmaceuticals Private Limited | ₹6.47 Cr (FY 2024) | 750.0% | New Delhi, Delhi, India |
To see the full peer comparison of Alleviare Life Sciences Private Limited, buy the company report.
Auditor
Alleviare Life Sciences Private Limited is audited by NITIN MITTAL & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NITIN MITTAL & CO | FY 2020 | 017642N |
Shareholding
The shareholding of Alleviare Life Sciences Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Alleviare Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Alleviare Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alleviare Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Alleviare Life Sciences has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAMCA2111M1ZR | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Alleviare Life Sciences Private Limited, buy the company report.
Recent activity
Alleviare Life Sciences Private Limited has 10 board changes on record since 2015: 2 appointments and 8 cessations. The latest: Puneet Poddar ceased to be Additional Director on 30 Jul 2024.
AGM
Alleviare Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Alleviare Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Ceased
Puneet Poddar ceased to be Additional Director.
Ceased
Vaibhav Bansal ceased to be Additional Director.
Appointed
Puneet Poddar was appointed as Director.
Appointed
Vaibhav Bansal was appointed as Director.
Ceased
Manoj Goyal ceased to be Additional Director.
Ceased
Ritu Goyal ceased to be Additional Director.
Ceased
Babu Nand Pandit ceased to be Director.
Ceased
Harish Chandra ceased to be Additional Director.
Ceased
Navendu Kumar Behera ceased to be Director.
Ceased
Sanjeev Kansal ceased to be Director.
1 earlier event is in the company report.
Frequently asked questions
Alleviare Life Sciences is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 December 2013 (13+ years old) and is registered under CIN U74999DL2013PTC261897.
Alleviare Life Sciences has 2 current directors:
- Vaibhav Bansal - Director
- Puneet Poddar - Director
The latest financial statements of Alleviare Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Alleviare Life Sciences is 07AAMCA2111M1ZR, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Alleviare Life Sciences is U74999DL2013PTC261897. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alleviare Life Sciences was incorporated on 10 December 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Alleviare Life Sciences by revenue are Alwin Willcure Pharmaceuticals Private Limited, Genesia Pharmaceuticals (India) Private Limited, Rawia International Healthcare Private Limited, Daikon Pharmaceuticals Private Limited, Bravo Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Puneet Poddar ceased to be Additional Director on 30 Jul 2024. Vaibhav Bansal ceased to be Additional Director on 30 Jul 2024. Puneet Poddar was appointed as Director on 15 Nov 2023. Alleviare Life Sciences has 10 board changes on record in total.
Yes, Alleviare Life Sciences is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-08-0011241).
Alleviare Life Sciences can be reached through the website alleviareindia.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Alleviare Life Sciences is at S – 9 Mezzanine Floor Uphaar Cinema Complex Green Park Extension, New Delhi, Delhi, India – 110016.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages